HIV Treatment Study
An International, Multicenter, Prospective Observational Study of the Safety of Maraviroc Used with Optimized Background Therapy in Treatment-Experienced HIV-1 Infected Patients
Protocol ID
08-02-160
Protocol Description
Maraviroc is a drug that is approved for HIV-1 infected patients. In this study, the safety of maraviroc, its long-term effects on HIV infection, and how well people tolerate it will be evaluated.
Eligibility Criteria
Patients with HIV
Primary Investigator(s)
- Joseph McGowan, MD